%0 Journal Article
%T Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study.
%A Strain, W David
%A Lukashevich, Valentina
%A Kothny, Wolfgang
%A Hoellinger, Marie-José
%A Paldánius, Päivi Maria
%J The Lancet
%V 382
%N 9890
%P 409-416
%@ 0140-6736
%D 2013-09-16
%~ DeepDyve